2020 CRA CORPORATE MEMBER PROSPECTUS

CRA SUSTAINS ADVOCACY FOCUS

R

R

R

R

R

CRA was actively involved in legislative and regulatory issues in 2019, including: }Regulation and transparency for PharmacyBenefitManagers(PBM) }Increasing transparancy into utilization review and prior authorization results from health plans and health insurers }Medi-Cal “clawback” of monies paid to pharmacies

CRA provided extensive issues support in 2019 through membership, Calls to Action, CRA Position Letters, and On-Site Advocacy

CRA supported federal efforts on patient andphysician issues: }CRA signed & co-signed letters on federal legislative and regulatory issues

CRA meets with regulators, including the Department of Managed Health Care and theDepartment of Insurance, educating them on issues with payors impacting our patients and our ability to practice the best medicine for our patients

CRA provides advocacy engagement and issuesawareness online through social media including Twitter @calrheum

CRA keeps members up-to-date with the latest news impacting the rheumatic community through legislative newsletters, e-blasts, and theCRA website

CRA prepares members with advocacy and legislative committee testimony training

CRA offers educational resources and advocacylegislative committee testimony training }CRA Annual Meeting }Webinars }Member Advocacy Day in Sacramento

CRA offers a growing number of advocacy resources on our website for our members, patients, and the public

R

R

R

On Twitter: @CalRheum

CRA GROWS IMPACT & PARTNERSHIPS

R

R

R

R

CRA continues to engage at both the local and state level on behalf of its members to encouragethe transparency and oversight of PharmacyBenefitManagers(PBMs).Lastyear,CRAjoinedthe Alliance for Transparency and Affordable Prescriptions(ATAP)tosupporttheireffortsinaddressing the impact PBMs have on prescription drug costs and patient access to affordable treatment.

Although there was no legislation in 2019 related to PBMs, CRA is speaking with organizations on their interest to pursue legislation around increasedPBMtransparencyin2020.

We will continue working on issues rheumatologists face whether legislativelyorregulatorily.

CollaborationhelpsaugmentCRA’seffectiveness.CRA works with groups and partners such as:}Coalition of State Rheumatology Organizations}Arthritis Foundation}American College of Rheumatology}Otherdisease-specificpatientgroups such as the National Psoriasis Foundation}California Medical Association}California Pharmacists Association

CRA continued to participate in the Joint Advocacy Day with the California Arthritis Foundation and the National Psoriasis FoundationinSacramentoonMay20,2019.

CRA also participates in a number of issue-basedcoalitions including the California Chronic Care Coalition, Californians for Access to Life-Saving Medicines, and Californians Allied for Patient Protection.

CRA LOOKS INTO PBMs

COLLABORATION

l Membership in CRA Industry Council, including 4 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl NamedsponsorofBoardofDirectorsmealand/orgeneralattendeesmealinconjunction withtheAnnualMeeting(sponsortocoverallcostsassociatedwiththemeal)l First right of refusal for the Board Dinner sponsorship at the Annual Meetingl Named sponsorship of mealinconjunctionwithAdvocacy Day program(sponsortocover costsassociatedwithmeal)l Meeting between the CRA Advocacy Committee and sponsor representative at the VP level oraboveinconjunctionwiththeACRAnnualMeetingintheFall.l Meeting with select CRA Board Members in the Falll Quarterly conference calls or in-person meetings with CRA President to discuss clinical and/ or advocacy issues affecting California rheumatologyl Monthly conference calls or in-person meetings with CRA Executive Director, as requested, to discuss educational, legislative, or regulatory, and/or payer relations issues impacting California rheumatologyl PartnerwithCRAoncommoninterestlegislative,regulatoryormedicalpolicyissues.l Sponsorship of 2 webinars a year on a mutual legislative, regulatory or educational priority of whichCRAwillpromotetoitsmembership(Boardapprovaloftopicnecessary.Sponsorto coverallcostsofthewebinar).l New company announcements(upto6ayear)onCRA’swebsitein“ExternalNews”and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support on CRA website homepage as well as recognition on “Our Partners” page with link to sponsor’s homepagel Acknowledgement of corporate support in member e-newsletters with logo and link to homepagel Access to members’ only section of CRA website(1account,whichmustbeidentifiedby thesponsor),includingmembershipdirectoryandonlinemessageboardareas.l Sponsorship recognized at the Annual Board Meetingl Complimentarycopy(upto5)ofAnnualMeetingSyllabus

DIAMOND LEVEL $50,000

l Membership in CRA Industry Council, including 2 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl NamedsponsorofBoardofDirectorsmealand/orgeneralattendeesmealinconjunction withtheAnnualMeeting(sponsortocoverallcostsassociatedwiththemeal)l Meeting with select CRA Advocacy Committee at the Annual Meetingl Meeting between the CRA Advocacy Committee and sponsor representative at the VP level oraboveinconjunctionwiththeACRAnnualMeetingintheFall.l Bi-annual conference calls or in-person meetings with CRA President to discuss clinical and/ or advocacy issues affecting California rheumatologyl Quarterly conference calls or in-person meetings with CRA Executive Director, as requested, to discuss educational, legislative, or regulatory, and/or payer relations issues impacting California rheumatologyl Partner with CRA on common interest legislative, regulatory or medical policy issuesl New company announcements(upto4ayear)onCRA’swebsitein“ExternalNews”and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support on CRA website homepage as well as recognition on “Our Partners” page with link to sponsor’s homepagel Acknowledgement of corporate support in member e-newsletters with logo and link to homepagel Access to members’ only section of CRA website(1account,whichmustbeidentifiedby thesponsor),includingmembershipdirectoryandonlinemessageboardareas.l Sponsorship recognized at the Annual Board Meetingl Complimentarycopy(upto4)ofAnnualMeetingSyllabus

PLATINUM LEVEL $30,000

l Membership in CRA Industry Council, including 2 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl Meeting between the CRA Advocacy Committee and sponsor representative at the VP level oraboveinconjunctionwiththeACRAnnualMeetingintheFall.l Annual conference calls or in-person meetings with CRA President to discuss clinical and/ or advocacy issues affecting California rheumatologyl Quarterly conference calls or in-person meetings with CRA Executive Director, as requested, to discuss educational, legislative, or regulatory, and/or payer relations issues impacting California rheumatologyl Partner with CRA on common interest legislative, regulatory or medical policy issuesl New company announcements(upto2ayear)onCRA’swebsitein“ExternalNews”and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support on CRA website homepage as well as recognition on “Our Partners” page with link to sponsor’s homepagel Acknowledgement of corporate support in member e-newslettersl Sponsorship recognized at the Annual Board Meetingl Complimentarycopy(upto3)ofAnnualMeetingSyllabus

GOLD LEVEL $20,000

l Membership in CRA Industry Council, including 1 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl Partner with CRA on common interest legislative, regulatory or medical policy issuesl New company announcements(upto2ayear)onCRA’swebsitein“ExternalNews”and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support in member e-newslettersl Acknowledgement of corporate support on CRA website on “Our Partners” webpage with link to sponsor’s homepagel Sponsorship recognized at the Annual Board Meetingl Complimentarycopy(upto2)ofAnnualMeetingSyllabus

l Acknowledgement of corporate support on CRA website on “Our Partners” webpage with link to sponsor’s homepagel Sponsorship recognized at the Annual Board Meetingl Complimentarycopy(upto2)ofAnnualMeetingSyllabus

SILVER LEVEL

BRONZE LEVEL

$10,000

$5,000

“Advocacy for Patient Access to Rheumatology Care”MISSION STATEMENT

FOR MORE INFORMATION

Shanna CastroExecutive Director

Email: info@calrheum.orgPhone:(310)536-0460

Tim MaddenGovernment Affairs

Email: madden@mqadvocacy.comPhone:(916)498-3352

www.calrheum.org

SAVE THE DATECRA16th ANNUAL MEETING

May 15 - 17, 2020

Marriott Marquis San Francisco CA

SAVE THE DATECRA ADVOCACY SUMMIT

May 2020

Sacramento, California

CORPORATE MEMBERSHIP FORMCalifornia Rheumatology Alliance | 2020

q

q

q

q

q

q

Sponsoring Company: Corporate Address: City: State: Zip: Country: Phone: Fax:

Please complete relevant contact information below:

My company would like to become:

Please list your company focus and product:

Agreement: I am an authorized representative for this company with full power and authority to sign this application. The company agrees to pay for sponsorship as noted on this form.

Authorized Signature: _________________________________ Date: __________________________

Please make checks payable and send to:

General Contact Information Government Relations/Advocacy Contact

Product/Brand Manager Contact

Name:Title:Address:City, State, Zip:Phone:Email:

Copy of me all correspondence related to CRA

Name:Title:Address:City, State, Zip:Phone:Email:

Copy of me all correspondence related to CRA

Name:Title:Address:City, State, Zip:Phone:Email:

Copy of me all correspondence related to CRA

California Rheumatology Alliance5230PacificConcourseDrive

Suite 100LosAngeles,CA90045

CRAFIN#33-1095347

q Gold $20,000 q Silver $10,000 q Bronze$5,000q Diamond$50,000 q Platinum$30,000